KELLY PAUL EDWARD purchased 13.3% of their position (25K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $64.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/11/2024ACC: 0001213900-24-077791
Director
Since Oct 2018
+25K
Net shares
Net buyer
$64.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$2.59
Trade value
$64.75K
% of position
13.3%
9/9/2024
187.29K→212.29K
Total
Net shares
+25K
Net value
$64.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2024 | P · Purchase | +25K | $2.59 | $64.75K | 13.3% | 187.29K | 212.29K |
| Total | +25K | $64.75K | ||||||
Derivative Transactions0
No derivative transactions reported